Your browser doesn't support javascript.
loading
Malignant transformation of fibrous dysplasia: A case report.
Hatano, Hiroshi; Morita, Tetsuro; Ariizumi, Takashi; Kawashima, Hiroyuki; Ogose, Akira.
Afiliação
  • Hatano H; Department of Orthopedic Surgery, Niigata Cancer Center Hospital, Niigata 951-8566, Japan.
  • Morita T; Department of Orthopedic Surgery, Niigata Cancer Center Hospital, Niigata 951-8566, Japan.
  • Ariizumi T; Department of Orthopedic Surgery, Niigata Cancer Center Hospital, Niigata 951-8566, Japan.
  • Kawashima H; Division of Orthopedic Surgery, Department of Regenerative and Transplant Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
  • Ogose A; Division of Orthopedic Surgery, Department of Regenerative and Transplant Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Oncol Lett ; 8(1): 384-386, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24959281
ABSTRACT
Secondary osteosarcoma from fibrous dysplasia (FD) is very rare. The etiology of FD is linked to activating missense mutations of the guanine nucleotide-binding protein α-subunit (GNAS) gene, which encodes the stimulatory α subunit of the G protein (Gsα) and is located at chromosome 20q13. These mutations are central to the pathogenesis of FD; however, it is not known whether Gsα mutations are retained following malignant transformation in FD. In addition, to the best of our knowledge, no studies have been performed on chromosomal analysis of secondary osteosarcoma from FD. The present study presents a case of secondary osteosarcoma arising from polyostotic FD in a 72-year-old male. Chromosomal analysis showed 44, X, -Y, add(4)(p11), add(5)(p15), der(11)add(11)(p15)t(1;11)(q21;q23), add(12)(q11), -13, der(22)t(12;22)(q11;p12). Reverse transcription-polymerase chain reaction (RT-PCR) analysis demonstrated the presence of a Gsα mutation in both the primary tumor cells and secondary osteosarcoma cells. There was no alteration in this mutation in the region of malignant transformation, which suggests that this mutation may be a useful clinical marker for distinguishing de novo osteosarcoma (primary osteosarcoma) from secondary osteosarcoma arising from FD.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncol Lett Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Japão País de publicação: GR / GRECIA / GREECE / GRÉCIA

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncol Lett Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Japão País de publicação: GR / GRECIA / GREECE / GRÉCIA